Furthermore, higher levels of MUC5AC were observed in the COPD III–IV FMT mouse group and expression of MUC2 was higher in both COPD FMT mouse groups (p < 0.01 or 0.01, Fig. 10b). This evidence concerns the gene MUC5AC and chronic obstructive pulmonary disease.